| B Lymphocyte commitment program is driven by the proto-oncogene c-Myc. | None |
| Glucocorticoids regulate expression of the v-mycOK10 oncogene in a murine retroviral vector with chimeric MoMuLV-MMTV LTRs. | None |
| c-myc oncoprotein in bronchial carcinoma: expression in all major morphological types. | None |
| Regulation of the equilibrium between G-quadruplex and duplex DNA in promoter of human c-myc oncogene by a pyrene derivative. | None |
| Long-term cultivation of in vitro Apis mellifera cells by gene transfer of human c-myc proto-oncogene. | None |
| Proteolytic control of the oncoprotein transcription factor Myc. | None |
| describes the functions of c-myc and its role as oncogene, assessing its expression by immunohistochemistry and genetic amplification studies [review] | None |
| What real influence does the proto-oncogene c-myc have in OSCC behavior?. | None |
| Real-time monitoring of PCR amplification of proto-oncogene c-MYC using a Ta(2)O(5) electrolyte-insulator-semiconductor sensor. | None |
| These results demonstrate a novel pathway of estrogen regulation of gene expression by cooperation between ER and AP-1 at the distal enhancer element and that AP-1 is involved in estrogen induction of the c-myc oncogene. | None |
| Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms. | None |
| Overexpression of the c-myc oncogene inhibits nonsense-mediated RNA decay in B lymphocytes. | None |
| shRNA-mediated suppression of the high levels of MYC in recurring T-ALL tumors elicited both suppression of proliferation and increased apoptosis, confirming that these tumors remain oncogene addicted. | None |
| Suppression of Myc oncogenic activity by nucleostemin haploinsufficiency. | None |
| The human papillomavirus type 16 E7 oncoprotein targets Myc-interacting zinc-finger protein-1. | None |
| let-7a acts as a tumor suppressor in RCC cell lines by down-regulating c-myc and c-myc target genes. | None |
| Transfection of DLL4 into K562 cells increased the protein expression levels of transcription factor YY1 and proto-oncogene c-Myc, which slowed cell proliferation and increased apoptosis. | None |
| The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop. | None |
| E2F1: a potential negative regulator of hTERT transcription in normal cells upon activation of oncogenic c-Myc. | None |
| Regulation of gene transcription by the oncoprotein MYC. | None |